Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stevanato Group S.p.A (STVN) Current Leases (2020 - 2025)

Stevanato Group S.p.A (STVN) reported Current Leases of $5.1 million for Q4 2025, down 6.26% year-over-year from $5.4 million in Q4 2024, and down 6.26% on a QoQ basis from $5.4 million in Q4 2024.

Stevanato Group S.p.A (STVN) has 6 years of Current Leases data on file, last reported at $5.1 million in Q4 2025.

  • Quarterly Current Leases fell 6.26% year-over-year to $5.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.1 million (down 6.26% YoY) and the FY2025 annual result came in at $5.1 million, down 6.26% from the prior year.
  • Current Leases fell to $5.1 million in Q4 2025 per STVN's latest filing, from $5.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $22.8 million in Q2 2021 and bottomed at $5.1 million in Q4 2025.
  • The 5-year median for Current Leases is $5.9 million (2023), against an average of $8.6 million.
  • The widest annual swing landed in 2022, when Current Leases slipped 14.48%; it then rose 15.68% in 2023.
  • Tracing STVN's Current Leases over 5 years: stood at $6.4 million in 2021, then dropped by 14.48% to $5.4 million in 2022, then gained by 15.68% to $6.3 million in 2023, then decreased by 13.42% to $5.4 million in 2024, then declined by 6.26% to $5.1 million in 2025.
  • Per Business Quant, the three latest STVN Current Leases figures stand at $5.1 million (Q4 2025), $5.4 million (Q4 2024), and $6.3 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 29.23 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 21.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Stevanato Group S.p.A 5.73 Bn 5.59 Bn 88.04 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 5.10 Mn
Dec 31, 2024 5.44 Mn
Dec 31, 2023 6.28 Mn
Dec 31, 2022 5.43 Mn
Dec 31, 2021 6.35 Mn
Jun 30, 2021 22.80 Mn
Dec 31, 2020 6.48 Mn